The company has already identified molecules it believes can improve the removal of damaged or misfolded proteins that accumulate with aging and lead to diseases such as Alzheimer’s, Parkinson’s, amyloidosis, and other age-related neurodegenerative diseases. These drugs aim to target the autophagy process helping our bodies clean out the cellular garbage and restore homeostasis and function lost due to the aging process.